Hepatic encephalopathy · prevention and treatment of hepatic encephalopathy in people with cirrhosis
It is very uncertain whether lactulose changes hepatic encephalopathy compared with lactitol (very low certainty).
1 finding from 1 review
Serious adverse events · prevention and treatment of hepatic encephalopathy in people with cirrhosis
It is very uncertain whether lactulose changes serious adverse events compared with lactitol (very low certainty).
1 finding from 1 review
Secondary outcome: quality of life · prevention and treatment of hepatic encephalopathy in people with cirrhosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Overall survival · 578 patients with early HCC
1 finding from 1 review
Local progression · 1088 patients with early HCC
1 finding from 1 review
Rate of complications · 1088 patients with early HCC
1 finding from 1 review
Length of hospital stay · 1088 patients with early HCC
1 finding from 1 review
2‐year survival‐ · 578 patients with early HCC
1 finding from 1 review
Event‐free survival · 578 patients with early HCC
1 finding from 1 review
Local progression · 578 patients with early HCC
1 finding from 1 review
Rate of complications · 578 patients with early HCC
1 finding from 1 review
Length of hospital stay · 578 patients with early HCC
1 finding from 1 review
Overall survival · 1088 patients with early HCC
1 finding from 1 review
2‐year survival · 1088 patients with early HCC
1 finding from 1 review
Event‐free survival · 1088 patients with early HCC
1 finding from 1 review
Intervention not reported
Peg interferon vs.control · Participants with recurrent liver graft infection with hepatitis C virus.
It is very uncertain whether the intervention changes peg interferon vs.control (very low certainty).
1 finding from 1 review
Intervention not reported
Peg interferon plus ribavirin vs.control · Participants with recurrent liver graft infection with hepatitis C virus.
It is very uncertain whether the intervention changes peg interferon plus ribavirin vs.control (very low certainty).
1 finding from 1 review
Intervention not reported
Ribavirin plus peg interferon vs.peg interferon · Participants with recurrent liver graft infection with hepatitis C virus.
It is very uncertain whether the intervention changes ribavirin plus peg interferon vs.peg interferon (very low certainty).
1 finding from 1 review
Intervention not reported
Interferon vs.control · Participants with recurrent liver graft infection with hepatitis C virus.
It is very uncertain whether the intervention changes interferon vs.control (very low certainty).
1 finding from 1 review
Intervention not reported
Interferon plus ribavirin vs.control · Participants with recurrent liver graft infection with hepatitis C virus.
It is very uncertain whether the intervention changes interferon plus ribavirin vs.control (very low certainty).
1 finding from 1 review